nonprofit logo

The Translational Pulmonary And Immunology Research Center

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 472364652 ✦ Long beach, CA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is The Translational Pulmonary And Immunology Research Center?

The Translational Pulmonary and Immunology Research Center is a non-profit institute in Long Beach, California, dedicated to combining basic, translational research, clinical care, and advocacy for five specific medical conditions: adult cystic fibrosis, food allergy and intolerance, bronchiectasis, immune deficiency, and airway inflammatory disorders. Their mission is to enable specialists, including clinical physician-researchers, scientists, and advocates, to collaborate effectively in a single environment to develop cutting-edge, personalized treatment protocols for rare and orphan diseases. The center aims to advance treatment discovery at a pace that benefits patients today while building a scalable model to accelerate the rate of research discovery for all diseases. The center houses approximately 228 employees.


Official website here: www.tpric.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 76% (Three-Star out of Four Stars)

The Translational Pulmonary And Immunology Research Center has received a Three-Star rating from Charity Navigator, indicating a satisfactory level of accountability and finance management. The rating is based entirely on a single beacon score, demonstrating that the organization performs well in several key financial areas, including a majority of independent board members and effective financial oversight.

Strengths of the organization include a well-composed board with a high percentage of independent members, which suggests strong governance practices. The center has also demonstrated effective management of its financial statements with an audit and oversight committee in place, and it has shown no material diversion of assets. However, some policies, such as conflict of interest and whistleblower policies, are missing, which may raise concerns regarding transparency and risk management.

While the financial ratios indicate a decent allocation of resources towards program expenses, the organization could improve its performance in this area to ensure a higher percentage of funds directly supports its mission. Overall, while the Translational Pulmonary And Immunology Research Center shows promising practices in governance and finance, addressing the gaps in its policy framework could enhance its rating in future assessments.


This AI summary has been generated from information found on Charity Navigator.

Is The Translational Pulmonary And Immunology Research Center legitimate?

The Translational Pulmonary And Immunology Research Center is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Translational Pulmonary And Immunology Research Center submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $360,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $4,653,188

For more financial information, click here


Official website here: www.tpric.org

What is the mission statement of The Translational Pulmonary And Immunology Research Center?

The Translational Pulmonary and Immunology Research Center is a non-profit clinical care and research facility dedicated to advancing treatments for rare and orphan diseases. Their mission is twofold: to improve patient care with cutting-edge individualized treatment protocols using comprehensive diagnostic tools and patient-driven research, and to build a scalable model for accelerating research discovery for all diseases. The Center specializes in five medical conditions: adult cystic fibrosis, food allergy and intolerance, bronchiectasis, immune deficiency, and airway inflammatory disorders. Their goal is to speed up the pace of treatment discovery to benefit patients today and establish a successful model to boost research progress for various diseases.


Official website here: www.tpric.org

Who is the CEO of The Translational Pulmonary And Immunology Research Center?

Dr Inderpal Randhawa is the Founder/Ceo/Chairman of The Translational Pulmonary And Immunology Research Center. The CEO's salary of The Translational Pulmonary And Immunology Research Center is $360,000 and their total compensation is $360,000.


Official website here: www.tpric.org

What is the revenue of The Translational Pulmonary And Immunology Research Center?

The Translational Pulmonary And Immunology Research Center's revenue in 2022 was $13,971,244.


Official website here: www.tpric.org

Who are the executives of The Translational Pulmonary And Immunology Research Center and what are their salaries?

The average compensation at The Translational Pulmonary And Immunology Research Center during 2022 was $21,988. There are 228 employees and 6 volunteers at The Translational Pulmonary And Immunology Research Center.


Here are 10 key members and their salaries (The Translational Pulmonary And Immunology Research Center's CEO's salary is $360,000 and their total compensation is $360,000):


Inderpal Randhawa Md (Founder/Ceo/Chairman)
  • Compensation: $360,000
  • Related: $0
  • Other: $0
Jeffrey Shapack (Board Of Director - Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Palma Gallegos (Board Of Director - Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paul Orlin (Board Of Director - Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Anoop Lohara (Chief Operating Officer)
  • Compensation: $18,383
  • Related: $0
  • Other: $1,395
Lida Mohtasham (Physician)
  • Compensation: $206,881
  • Related: $0
  • Other: $16,067
Dibanni Vasquez (Physician (Thru 8/31/22))
  • Compensation: $160,898
  • Related: $0
  • Other: $8,622
Vivian Aranez (Physician (Thru 7/31/22))
  • Compensation: $147,628
  • Related: $0
  • Other: $4,328
Peter Ngo (Laboratory Manager)
  • Compensation: $141,795
  • Related: $0
  • Other: $0
Nathan Marsteller (Lab Scientist)
  • Compensation: $132,745
  • Related: $0
  • Other: $7,454


Official website here: www.tpric.org

Where can I find the form 990 for The Translational Pulmonary And Immunology Research Center?

The Translational Pulmonary And Immunology Research Center's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.tpric.org

Learn more at the official website: www.tpric.org

Mission Statement of The Translational Pulmonary And Immunology Research Center

The Translational Pulmonary and Immunology Research Center (TPIRC) is a pioneering non-profit clinical care and research facility dedicated to advancing treatments for rare and orphan diseases.Focusing on five specific medical conditions, namely adult cystic fibrosis, food allergy and intolerance, bronchiectasis, immune deficiency, and airway inflammatory disorders, TPIRC brings together clinical physician researchers, scientists, and advocates in a collaborative and efficient environment.

The mission of TPIRC is twofold. Firstly, it aims to develop cutting-edge, individualized treatment protocols for patients suffering from these conditions using comprehensive diagnostic tools and patient-driven research. By accelerating treatment discovery at a pace that benefits patients today, TPIRC strives to make a significant difference in their lives.

Secondly, TPIRC is building a scalable model of success to expedite the rate of research discovery for all diseases. This means that the advancements made in treating these rare conditions can pave the way for more rapid progress in finding cures for a broader range of diseases. In essence, TPIRC's mission is to create a unique opportunity for specialists in the rare disease community to work together, combining their expertise to improve patient care and drive innovation in medical research.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The Translational Pulmonary and Immunology Research Center (TPIRC) has made significant strides in addressing the challenges associated with rare diseases, particularly in the fields of pulmonary and immunology disorders. By providing a collaborative environment for clinical physician researchers, scientists, and advocates, TPIRC facilitates a unique synergy that enhances research and treatment development.

Focusing on five critical medical conditions—adult cystic fibrosis, food allergy and intolerance, bronchiectasis, immune deficiency, and airway inflammatory disorders—the center integrates basic and translational research with advanced clinical care. This holistic approach not only improves patient outcomes but also fosters innovation in treatment protocols tailored to the individual needs of patients.

TPIRC's emphasis on patient-driven research ensures that the voice of the patient is central to the discovery process, leading to more relevant and effective interventions. Additionally, the center's commitment to disease education and awareness coupled with advocacy and fundraising initiatives amplifies its impact on the broader community, raising attention and resources for these often-overlooked medical conditions.

By building a scalable model of success, TPIRC aims not only to accelerate the pace of research discovery for its focus areas but also to serve as a foundational blueprint for research efforts across other rare and orphan diseases. This dual mission empowers not only current patients but also paves the way for future advancements in the understanding and treatment of complex medical conditions.




This information is meant to be a general summary of The Translational Pulmonary And Immunology Research Center. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$13,971,244 (2022)
Expenses
$12,569,336 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $72
  • Program Service Revenue: $11,894,955
  • Gross Receipts: $13,971,244

Assets and Liabilities:

  • Total Assets: $5,168,526
  • Total Liabilities: $2,963,128
  • Net Assets: $2,205,398

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

DIAGNOSTIC SERVICES

Revenue

$8,269,366

PATIENT REVENUE

Revenue

$3,326,273

CLINICAL PATIENT SERVI

Revenue

$293,256

OTHER REVENUE

Revenue

$6,060

Organization Details

Founding Year

2014

Principal Officer

Dr Inderpal Randhawa

Main Address

701 E 28TH STREET SUITE 116, LONG BEACH, CA, 90806

NTEE Category

Code: E24 - Health

If you are a representative of The Translational Pulmonary And Immunology Research Center and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.